Resmed Inc. buy Morgan Stanley
Start price
21.10.25
/
50%
€230.40
Target price
21.10.26
€261.08
Performance (%)
-14.63%
Price
13.08.26
€196.70
Summary
This prediction is currently active. The prediction for Resmed Inc. disappoints with a performance of -14.63%. This prediction currently runs until 21.10.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | 1.056% | 1.056% |
| iShares Core DAX® | 0.625% | 4.952% |
| iShares Nasdaq 100 | 1.160% | -1.160% |
| iShares Nikkei 225® | 2.356% | -1.354% |
| iShares S&P 500 | 0.631% | 1.380% |
Comments by Morgan_Stanley for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) had its price target raised by analysts at Morgan Stanley from $298.00 to $304.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat